Clinical evaluation of Montelukast plus Budesonide nasal spray and Desloratadine citrate disodium in treating moderate and severe persistent allergic rhinitis
-
摘要: 目的: 探讨孟鲁司特钠联合布地奈德鼻喷雾剂和枸地氯雷他定治疗中-重度持续性变应性鼻炎(AR)的临床疗效。方法: 随机将70例中-重度持续性AR患者分为实验组(35例)和对照组(35例),实验组给予孟鲁司特钠口服,布地奈德鼻喷雾剂喷鼻,枸地氯雷他定片口服;对照组给予布地奈德鼻喷雾剂喷鼻,枸地氯雷他定片口服。疗程各4周。比较2组患者治疗前、后鼻部症状视觉模拟量表(VAS)评分、鼻-结膜炎相关生活质量(RQLQ)评分及总有效率。结果: ①鼻部症状VAS评分:实验组在治疗2周及4周时鼻部症状VAS总评分及各项评分与对照组比较,差异均有统计学意义(P<0.05);②RQLQ评分:4周后2组患者RQLQ评分与治疗前比较均有显著改善,实验组患者鼻部症状评分与对照组比较差异有统计学意义(P<0.05);③总有效率:实验组总有效率(94.29%)与对照组(80.00%)比较,差异有统计学意义(P<0.05)。结论: 孟鲁司特钠联合布地奈德鼻喷雾剂及枸地氯雷他定在治疗中-重度持续性AR过程中,可以共同发挥作用,迅速缓解临床症状,提高中-重度持续性AR患者的生活质量。Abstract: Objective: To investigate the clinical efficacy of montelukast plus budesonide nasal spray and desloratadine citrate disodium tablets on moderate and severe persistent allergic rhinitis. Method: Senenty patients with moderate and severe persistent allergic rhinitis were devided randomly study group (n=35) and control group (n=35). The study group were treated with montelukast sodium tablets combined with budesonide nasal spray and desloratadine citrate disodium tablets for 4 weeks,the control group received budesonide nasal spray and desloratadine citrate disodium tablets for 4 weeks. Comparing visual analogue scale (VAS)scores of nasal symptoms,rhino conjunctivitis quslity of life questionnaire (RQLQ) scores and total effective rate in two groups at baseline and after treatment.Result: ①VAS scores of nasal symptoms:the difference of total nasal symptoms VAS scores or single nasal symptom VAS scores from both groups at 2 weeks and 4 weeks after treatment were statistically significant (P<0.05); ②RQLQ scores:the difference of RQLQ scores of 2 groups at baseline and 4 weeks after treatment were statistically significant, the difference of RQLQ scores about nasal symptoms in two groups at 4 weeks after treatment were statistically significant (P<0.05);③The total effective rate was 94.29% in study group but 80.00% in control group,the differences were statistically significant (P<0.05).Conclusion: Montelukast plus budesonide nasal spray and desloratadine citrate disodium tablets can work together better on relieving clinical syptoms quickly and promoting the life quality of patients with moderate and severe persistent allergic rhinitis.
-
Key words:
- rhinitis /
- allergic /
- montelukast /
- budesonide nasal spray /
- desloratadine citrate disodium tablets /
- treatment outcome
-
[1] 中华耳鼻咽喉头颈外科杂志编委会鼻科组,中华医学会耳鼻咽喉头颈外科学分会鼻科学组.变应性鼻炎诊断和治疗指南(2009年,武夷山)[J].中华耳鼻咽喉头颈外科杂志,2009,44(11):977-978.
[2] JUNIPER E F.Measuring health-related quality of life in rhinitis[J].J Allergy Clin Immunol,1997,99:S742-749.
[3] ROSENWASSER L.New insights into the pathophysiology of allergic rhinitis[J].Allergy Asthma Proc,2007,28:10-15.
[4] 张罗,周兵,韩德民,等.变应性鼻炎研究进展(三):鼻用皮质类固醇的药理作用[J].耳鼻咽喉-头颈外科,2004,11(1):67-72.
[5] 张罗,韩德民,顾之燕.抗组胺药物H1受体拮抗剂的临床药理学(一):组胺、组胺受体和抗组胺药物[J].中国耳鼻咽喉头颈外科,2005,12(1):61-64.
[6] VAN ADELSBERG J, PHILIP G, PEDINOFF A J, et al.Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period[J].Allergy,2003,58:1268-1276.
[7] LAGOS J A, MARSHALL G D. Montelukast in the management of allergic rhinitis[J]. Ther Clin Risk Manag,2007,3:327-332.
[8] GOH B S, ISMAIL M I, HUSAIN S. Quality of life assessment in patients with moderate to severe allergic rhinitis treated with montelukast and/or intransal steroids:a randomized,double-blind, placeb-cntrolled study[J]. J Laryngol Otol, 2014, 128:242-248.
[9] 孟娟,张虹婷,刘世喜.鼻用激素与孟鲁司特钠治疗中重度持续性变应性鼻炎的随机对照研究[J].中国耳鼻咽喉头颈外科,2010,17(11):567-570.
计量
- 文章访问数: 59
- PDF下载数: 17
- 施引文献: 0